Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
about
Interventions for emergency contraceptionInterventions for emergency contraceptionEndometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914Clinical applications of mifepristoneEmergency contraception in a travel context.Worldwide research productivity in emergency contraception: a bibliometric analysisContraceptive use of antiprogestin.The science, medicine, and future of contraceptionScience, medicine, and the future. ContraceptionEctopic pregnancy and emergency contraceptive pills: a systematic reviewMifepristone.Hormonal emergency contraception.Postfertilization effect of hormonal emergency contraception.Emerging options for emergency contraception.New developments in contraceptive drugs for use by women.Emergency contraception--clinical and ethical aspects.Progesterone antagonists and progesterone receptor modulators.Emergency contraception. Summary of the Society of Obstetricians and Gynaecologists of Canada's clinical practice guidelinesContraceptive applications of progesterone receptor modulators.Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology.Measuring and reporting of the treatment effect of hormonal emergency contraceptives.Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception.Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception.Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development.The safety of available and emerging options for emergency contraception.Current controversies with oral emergency contraception.Mifepristone versus the Yuzpe regimen (PC4) for emergency contraception.Six years of clinical experience using postcoital contraception in college women.RU-486: legal and policy issues confronting the Food and Drug Administration.Emergency postcoital treatment: practical and ethical barriers to use.Intrauterine contraceptive devices and antigestagens as emergency contraception.Gestagens, danazol and antiprogestogen in emergency contraception.Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo.Safety and effectiveness of hormonal postcoital contraception: a prospective study.Emergency contraception: is it time to change method?Deregulating emergency contraception.How to Escape the Doctor's Dilemma? De-Medicalize Reproductive Technologies.Emergency contraception: knowledge and attitudes of Turkish nursing and midwifery students.Contraceptive efficacy of daily administration of 0.5 mg mifepristone.Interventions for emergency contraception
P2860
Q24201465-8A3393AE-5E37-4965-A8D1-F31EB8FE1A99Q24243139-D8686203-1B74-4D43-B3A3-48EDCA7D91ECQ24601691-876F2B7D-754F-4450-9D6C-41EFA01D3AA5Q28278425-1D209F68-5D70-4D7C-86EE-461BF15A555AQ33539898-283EE49B-C8A2-4B66-994D-E722457E5171Q33632886-71AD1596-12BE-4948-9838-9533658945DCQ33700142-0B401937-2193-4BF2-86B7-DBB6B73F6819Q33727605-40D59114-8361-47A4-B34A-76F9957D25CDQ33748064-3434FB01-4727-4405-958A-B4BF8396EF62Q34117414-26C80797-4777-491B-BD04-1A02ADD31D79Q34284259-3E906856-DD00-470D-873D-1D7E1C43F0CBQ34496102-7765C84F-3500-44C9-8801-FA4A170C38F6Q34564299-616A9B05-AEAF-4022-B69F-0EDBF67ADC6EQ34659150-FA0CDF73-C1DB-4908-B4AA-CD6A25F47E6AQ34841753-E0B62D58-C2A0-4400-9698-1FB259928DD7Q35538477-A6EE3E31-0A33-4C72-96C2-97F097D90CD2Q35547299-C7299BBE-2172-4734-92B3-5FCF063FC780Q36059249-DE99D455-D91D-4600-A24F-376960BD97E1Q37280942-7C8AF851-A632-497E-9B62-AA186804BDE3Q37681583-53C10ADF-1946-4F59-816B-CCCBD05C6519Q37990846-173804BA-DDB2-454B-B264-AFF5931D6582Q38018780-0BFB1BCF-572D-4BFA-963A-5E521CA9CE58Q38179825-32993617-5AC9-4898-9479-49F9965B6088Q38569796-09161ACD-5E7B-4E27-953A-155617B9F582Q38668489-56621F1D-320B-4F44-BB80-F9897E13DAADQ39402949-6A492C7F-B7EF-40BE-A7F9-99A59B40564AQ40474896-3045E249-A26E-4155-8A00-17584A13F9D7Q40782307-6CBE635C-3B78-4E8F-BD76-35F2AAA67DFDQ41078005-65FB80E8-8A4F-42A4-BC34-FCD3E5E8EDDFQ41203127-80A5EF83-1648-445E-B65D-8D0673D13F92Q42053763-E5A343C2-D749-40E3-B171-A53F229A4718Q42056173-E3F94CAF-0615-49BA-AA92-71ABC52E3402Q42126206-AB417455-468E-4E2E-935B-885E812DE977Q42603578-A5B07064-78E1-4C07-8C1E-BFD765C07C2DQ42760465-276B4686-AE1B-464B-9D5A-E83721AD4337Q43150917-FCA5DEF1-B455-4EEF-AECD-AE2F2C666A17Q47662868-24BAF3D1-FE4F-4217-B24F-C81943FA4E5FQ47792178-7C288C1F-2CD6-4423-AF92-CD95BEB6253AQ53990815-3BA1F11A-EEFD-4C1A-83CD-1B7A7602617BQ56051167-EB8B4BEE-6E14-4ADF-9B33-CA41E1C38E30
P2860
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Mifepristone (RU 486) compared ...... ency postcoital contraception.
@en
type
label
Mifepristone (RU 486) compared ...... ency postcoital contraception.
@en
prefLabel
Mifepristone (RU 486) compared ...... ency postcoital contraception.
@en
P2093
P1476
Mifepristone (RU 486) compared ...... ency postcoital contraception.
@en
P2093
P304
P356
10.1056/NEJM199210083271501
P407
P577
1992-10-01T00:00:00Z